MedPath

Effects of Auricular Therapy in the treatment of Premenstrual Syndrome

Not Applicable
Recruiting
Conditions
Premenstrual syndrome
C23.550.568.968
Registration Number
RBR-9w92fv
Lead Sponsor
niversidade Federal do Paraná
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

WWomen aged 18-35 years; sedentary; university students enrolled regularly at the Federal University of Paraná; and who have Premenstrual Syndrome (mild to moderate) or Pre-Menstrual Dysphoric Disorder according to the criteria listed in the PSST (Premenstrual Syndrome Screening Tool)

Exclusion Criteria

Women classified by PSST as mild or absent Premenstrual Syndrome; in the gestational period; with irregular menstrual cycles (cycles less than 25 days or greater than 35 days); women diagnosed with secondary dysmenorrhea (fibroids, endometriosis or cysts); who have a history of abortion; cardiopathy; who use antidepressants and / or psychotropic medication in the last two months; and, that they have any type of lesion in the auricular pavilion.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement of the symptoms of premenstrual syndrome in at least 3 of the 14 symptoms listed by the PSST (Premenstrual Syndrome Screenning Tool) questionnaire. Data collected one week before the intervention, the fifth week, the week following the intervention (9th week) and a 4 week follow-up (13th week)
Secondary Outcome Measures
NameTimeMethod
Improvement in pain intensity (measured using the Nordic Symptom Questionnaire), anxiety (measured using the Beck Anxiety Inventory) and quality of life (measured using the WHOQoL-Bref questionnaire). intervention, in the week after the intervention (week 9) and a follow-up of 4 weeks (week 13)
© Copyright 2025. All Rights Reserved by MedPath